Opportunity for Pharmacists in Telehealth, Team-Based Care: Clinical Inertia

A variety of team-based telehealth interventions have recently been developed and piloted in a number of practice settings. Despite the variety of intervention designs, clinical inertia (CI) continues to be problematic for therapeutic intensification and subsequent disease control. Based on recent literature, pharmacists have the ability to mitigate a number of factors contributing to CI. Considering CI continues to limit overall effectiveness of team-based telehealth interventions, involving pharmacists more intentionally in these interventions would provide benefit to therapeutic intensification and therapeutic outcomes.